Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.

CO

Global Cord Blood (CO)

Global Cord Blood Corporation
일자:
정렬 기준:
 검색 관련기사 보기:NYSE:CO
일자시간출처헤드라인심볼기업
2024/04/2605:02Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:COGlobal Cord Blood Corporation
2024/04/1722:03Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:COGlobal Cord Blood Corporation
2024/03/2005:07Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:COGlobal Cord Blood Corporation
2024/03/1205:01Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:COGlobal Cord Blood Corporation
2023/09/0601:18Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:COGlobal Cord Blood Corporation
2023/06/2222:11Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NYSE:COGlobal Cord Blood Corporation
2023/06/0303:39Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:COGlobal Cord Blood Corporation
2023/04/1404:14PR Newswire (US)GLOBAL CORD BLOOD CORPORATION ANNOUNCES FAILURE TO FILE INTERIM FINANCIALSNYSE:COGlobal Cord Blood Corporation
2023/04/1404:08PR Newswire (US)GLOBAL CORD BLOOD CORPORATION ANNOUNCES FAILURE TO FILE INTERIM FINANCIALSNYSE:COGlobal Cord Blood Corporation
2023/04/1105:17Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:COGlobal Cord Blood Corporation
2023/03/0406:20Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:COGlobal Cord Blood Corporation
2023/02/0404:39Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NYSE:COGlobal Cord Blood Corporation
2023/02/0322:01Edgar (US Regulatory)Statement of Ownership (sc 13g)NYSE:COGlobal Cord Blood Corporation
2022/12/0306:07Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:COGlobal Cord Blood Corporation
2022/11/0105:03Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:COGlobal Cord Blood Corporation
2022/10/2206:15Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:COGlobal Cord Blood Corporation
2022/09/2705:07Business WireGlobal Cord Blood Corporation Announces Appointment of Joint Provisional Liquidators by The Grand Court Of The Cayman IslandsNYSE:COGlobal Cord Blood Corporation
2022/09/2403:07TipRanksGlobal Cord Blood trading halted by NYSE for ‘regulatory concern’NYSE:COGlobal Cord Blood Corporation
2022/09/2402:52Business WireThe Grand Court of the Cayman Islands Granted Blue Ocean’s Application to Appoint Joint Provisional Liquidators for Global Cord Blood CorporationNYSE:COGlobal Cord Blood Corporation
2022/08/2422:02Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NYSE:COGlobal Cord Blood Corporation
2022/08/1705:26Edgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)NYSE:COGlobal Cord Blood Corporation
2022/08/1705:16PR Newswire (US)Global Cord Blood Corporation Files Annual Report on Form 20-FNYSE:COGlobal Cord Blood Corporation
2022/08/0221:01Edgar (US Regulatory)Notification That Form 20-f Will Be Submitted Late (nt 20-f)NYSE:COGlobal Cord Blood Corporation
2022/07/0705:22Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:COGlobal Cord Blood Corporation
2022/07/0705:16PR Newswire (US)Global Cord Blood Corporation Obtained Injunction Order Against Blue Ocean in respect of Purported EGMNYSE:COGlobal Cord Blood Corporation
2022/07/0605:16PR Newswire (US)Global Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2022NYSE:COGlobal Cord Blood Corporation
2022/06/2721:02Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:COGlobal Cord Blood Corporation
2022/06/2305:01Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NYSE:COGlobal Cord Blood Corporation
2022/06/1801:49Dow Jones NewsGlobal Cord Blood Shares Rise 15% After Merger Target Gets FDA Clearance for INDNYSE:COGlobal Cord Blood Corporation
2022/06/1705:20PR Newswire (US)Global Cord Blood Corporation Announced Cellenkos Receives FDA Clearance of IND Application for CK0804 as Add on Therapy to Ruxolitinib for the Treatment of MyelofibrosisNYSE:COGlobal Cord Blood Corporation
 검색 관련기사 보기:NYSE:CO